Embrace TDD: Prospective, Multi-Center, Post Market Study to Evaluate Intrathecal (IT) Morphine as an Alternative to Systemic Opioids for the Treatment of Chronic, Intractable, Non-Malignant Primary Back Pain with or without Leg Pain

Project: Other project

StatusActive
Effective start/end date5/7/195/6/21

Funding

  • Medtronic, Inc.: $6,649.23